Drug Regulatory Authority of Pakistan, Ministry of National Health Services, Regulations Á Coordination, Islamabad

Our Leadership

Dr. Zafar Mirza

State Minister for NHSR&C

Captain(R) Zahid Saeed

Secretary, Mininstry of NHSR&C

Mr. Asim Rauf

Chief Executive Officer, DRAP

News & Alerts

Press Release [25th Feb, 2019]

DRAP Press Release on Price Increase [11th Jan, 2019]

S.R.O 1608 (I)/2018 - Pricing [03rd Jan, 2019]

S.R.O 1609 (I)/2018 - Pricing [03rd Jan, 2019]

S.R.O 1610 (I)/2018 - Pricing [03rd Jan, 2019]

Auction Notice [22nd January, 2019]

1st Meeting of Heads of National Medicines Regulatory Authorities (NMRAs) of Organization of Islamic Cooperation (OIC) at Jakarta, Republic of Indonesia [21-22 November, 2018]

Regulatory Information

Drug Regulatory Authority of Pakistan Act, 2012
Drugs Act, 1976
SROs
The Drugs (Labelling and Packing) Rules, 1986
The Drugs (Licensing, Registering & Advertising) Rules, 1976
The Drugs (Appellate Board) Rules, 1976
The Drugs (Research) Rules, 1978
The Drugs (Federal Inspectors, Federal Drug Laboratory & Federal Government Analysts) Rules, 1976
The Drugs (Imports & Exports) Rules, 1976
The Drugs (Specifications) Rules, 1978
The Northern Areas Drugs Rules

Recall Alerts

Abbott Vascular Absorb Bioresorbable Vascular Scaffold (BVS)

Safety alert - Increased rate of major adverse cardiac events observed in patients receiving Bioresorbable Vascular Scaffold (BVS)

Testing of 171,375 samples ensured under campaigns to curb spurious drugs sale

DRAP,as part of its special campaigns against spurious drugs in the country, has ensured testing of 1,71,375 samples at its laboratories during two years and nine months.

Jumex (Selegling HCL) 5MG, Tablets

Sanofi A-ventis Pak Ltd. recalled Jumax 5mg Tablets, Reg No:0101215 Batch No:7V001